5.3 Severe Pediatric Community-Acquired Pneumonia, Empyema & Pleural Space Infections
Key Takeaways
Age helps frame the differential for pediatric community-acquired pneumonia (CAP). Beyond early infancy, consider respiratory viruses and pneumococcus, assess for Staphylococcus aureus in severe complicated disease, and consider Mycoplasma pneumoniae in school-age children.
Escalate care for increasing respiratory support needs, respiratory exhaustion, altered mental status, or shock. In suspected septic shock, start empiric antimicrobials as soon as possible, ideally within one hour of recognition.
Choose initial IV antibiotics for severe complicated bacterial CAP using local guidance, prior cultures and risk factors. Necrotizing disease with shock warrants empiric coverage for pneumococcus and S. aureus, including MRSA.
The February 2026 IDSA/PIDS update suggests observing small uncomplicated effusions during pneumonia treatment. Drain moderate effusions with respiratory distress, large effusions, or purulent fluid. Chest ultrasound helps characterize moderate to large collections.
For most children 3 months to 18 years with empyema requiring drainage, the 2026 update conditionally favors tube drainage with fibrinolysis over initial surgery. It conditionally suggests a tube 12 Fr or smaller and alteplase alone. Extensive loculation or refractory disease may warrant video-assisted thoracoscopic surgery.
Severe Pediatric Community-Acquired Pneumonia and Empyema
A child with pneumonia can deteriorate because injured lung can no longer exchange gas, infected pleural fluid limits lung expansion, or sepsis impairs perfusion. Ask which of those problems is driving the change. Oxygen and ventilatory support treat respiratory failure, antimicrobials treat the infection, and pleural drainage provides source control when the collection is large, purulent, or contributing to respiratory compromise. Several interventions may be needed at once.
Age, presentation, and likely organisms
| Patient | Organisms to consider | How the finding changes the assessment |
|---|---|---|
| Neonate or young infant | Group B streptococcus and enteric gram-negative organisms in neonatal infection | Poor feeding, apnea, temperature instability, or poor perfusion may signal systemic infection. Use age-specific neonatal or young-infant evaluation and empiric treatment. |
| Infant or preschool child beyond early infancy | Respiratory viruses, pneumococcus, and in severe complicated disease, Staphylococcus aureus or group A streptococcus | Respiratory viruses are common in hospitalized children. A rapidly enlarging effusion or necrotizing consolidation with shock should raise suspicion for invasive bacterial infection. |
| School-age child or adolescent | Pneumococcus and respiratory viruses remain possible. Mycoplasma pneumoniae becomes more common. | A subacute cough and compatible epidemiology support considering atypical infection. A beta-lactam alone has no activity against Mycoplasma because it lacks a cell wall. |
Age guides the differential. Use the pace of illness, immunization and exposure history, and imaging to adjust it. Influenza can precede severe bacterial pneumonia. Cavitation, pneumatoceles, or a rapidly growing effusion in a toxic child increase concern for Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA). These signs cannot identify a specific organism or toxin.
Recognize respiratory failure and shock
Assess current oxygen needs, work of breathing, mental status, and perfusion against the child's recent trajectory. A falling respiratory rate in a child whose retractions are worsening and who is becoming drowsy can reflect fatigue. Escalate for increasing respiratory support, threatened ventilation, impaired airway protection, or poor perfusion. An oxygen saturation maintained only with substantial support can obscure how sick the child is. Trend the required support as well as the saturation.
Get blood cultures in severe or complicated pneumonia when feasible without materially delaying treatment. In suspected septic shock, the 2026 pediatric Surviving Sepsis Campaign recommends starting antimicrobials as soon as possible, ideally within an hour of recognizing sepsis. Obtain respiratory specimens when feasible and clinically indicated, such as a tracheal aspirate after intubation. Reassess support, perfusion, and the need for source control in parallel.
Choose and reassess empiric treatment
- In an otherwise healthy child with uncomplicated presumed bacterial CAP and up-to-date immunization, a narrow IV beta-lactam such as ampicillin may be appropriate when admission is needed and local susceptibility supports it.
- In severe complicated CAP with shock and concern for MRSA, provide prompt IV coverage for pneumococcus and S. aureus, including MRSA. Ceftriaxone plus vancomycin is one initial option in that setting. Use age, renal function, allergy history, local susceptibility, and pharmacy or infectious disease input to select and dose therapy.
- For serious MRSA infection, the vancomycin consensus guideline uses an area under the concentration-time curve (AUC) to minimum inhibitory concentration (MIC) target of 400–600 when the MIC is assumed to be 1 mg/L. Monitor exposure and renal function. After cultures and susceptibilities return, narrow therapy and reassess the need for additional agents.
- A compatible school-age presentation can prompt evaluation for atypical pathogens. Choose additional coverage using the clinical pattern and local guidance.
Identify the effusion that needs drainage
A parapneumonic effusion is pleural fluid associated with pneumonia. Early fluid may be free-flowing. Inflammatory fibrin can form septations and loculations that make drainage harder. Empyema denotes pus in the pleural space. With organization, a thick pleural peel can limit lung re-expansion. Persistent fever with increased work of breathing or asymmetric breath sounds should prompt assessment for a collection and other complications, including necrosis.
The February 2026 IDSA/PIDS update applies to children 3 months through 18 years. When the radiograph suggests a moderate to large collection, chest ultrasound can characterize its size and complexity and help plan drainage. It can be performed at the bedside without ionizing radiation. CT or MRI can characterize the collection when ultrasound is unavailable. Cross-sectional imaging may also help answer a separate question about parenchymal complications.
| Findings | Pleural management |
|---|---|
| Small uncomplicated effusion with minimal symptoms from the fluid | Treat pneumonia and observe the effusion. Further imaging is generally unnecessary at presentation. |
| Moderate effusion with respiratory distress, large effusion, or documented purulence | Arrange pleural drainage with the procedural and surgical teams. Send fluid collected at drainage for Gram stain and bacterial culture. |
| Continued compromise or persistent collection after drainage | Check drain function and position, re-image as indicated, and reassess source control with the procedural and surgical teams. |
Base the drainage decision on size, respiratory compromise, and evidence of infection in the pleural space. An adult pleural-fluid chemistry algorithm is a poor substitute for these findings in children. In a child with a large collection and respiratory distress, drainage is already indicated. Samples collected during drainage can identify a pathogen even when prior antibiotics make cultures less likely to grow an organism.
Select the drainage approach and monitor response
For most children with pneumonia-associated empyema requiring drainage, the guideline conditionally suggests chest tube drainage with intrapleural fibrinolysis before primary surgical debridement. It conditionally suggests a small-bore chest tube (12 Fr or smaller). A fibrinolytic such as alteplase (tPA) breaks down fibrin that separates pockets of fluid. Follow the institution's pediatric protocol for dose, dwell, and drainage settings and assess for bleeding and tube malfunction. The guideline conditionally favors alteplase alone. In the pediatric Livingston randomized trial, adding dornase alfa (DNase) did not significantly shorten hospital stay or reduce the need for additional drainage.
Video-assisted thoracoscopic surgery (VATS) can remove infected material and disrupt loculations directly. Consider it with the surgical team if extensive loculation makes tube drainage unlikely to suffice or if infected fluid persists after tube drainage and fibrinolysis. The comparative evidence for starting with a tube is of very low certainty. After drainage, trend oxygen requirement, work of breathing, perfusion, fever, tube function and output. Worsening shock or respiratory distress requires urgent reassessment.
Worked case
A 4-year-old being treated for pneumonia needs increasing oxygen and has markedly diminished left-sided breath sounds. Radiography suggests a large left pleural effusion. Ultrasound shows multiple septated pockets. Size and respiratory compromise warrant drainage. Collect pleural fluid during the procedure, review the antibiotic regimen, and discuss whether the anatomy favors tube drainage with fibrinolysis or early surgery. If the tube stops draining while the child still needs increasing oxygen, assess for blockage, displacement or an undrained pocket and re-engage the procedural team.
Clinical references include the Texas Children’s pediatric CAP pathway, UCSF pediatric antimicrobial guidance, pediatric sepsis recommendations, vancomycin consensus guideline, and the U.S. EPIC hospitalization study. See the UCSF neonatal early-onset sepsis pathway for the separate neonatal setting.
A 3-year-old with community-acquired pneumonia develops septic shock and respiratory failure. Imaging shows lobar consolidation, pneumatoceles, and a rapidly enlarging pleural effusion. The child has no known drug allergy or risk factors for Pseudomonas. Which empiric regimen best covers the likely bacterial pathogens while cultures are pending?
IV ampicillin alone.
IV ceftriaxone plus IV vancomycin.
Oral azithromycin plus oral amoxicillin-clavulanate.
Inhaled tobramycin alone.
A 9-year-old being treated for pneumonia has worsening retractions and rising oxygen needs. Chest ultrasound confirms a moderate parapneumonic effusion without visible septations. What is the next step?
Give diuretics and restrict maintenance fluids.
Continue antibiotics alone and repeat radiography in two days.
Wait for a pleural-fluid pH result before deciding on drainage.
Arrange pleural drainage and continue systemic antibiotics while culture and susceptibility results are pending.
A 6-year-old with pneumonia-associated empyema is scheduled for chest tube drainage with intrapleural fibrinolysis. What does the February 2026 IDSA/PIDS guideline suggest regarding dornase alfa?
Use intrapleural alteplase alone in preference to alteplase plus dornase alfa.
Add dornase alfa to alteplase routinely because it shortens hospital stay in children.
Use dornase alfa alone as the standard fibrinolytic treatment.
Use the adult combination regimen whenever a small-bore tube is selected.
Sections you finish are checked off in the contents.